Objective: Ghrelin and leptin play a role in control of food intake and adiposity but mechanisms regulating these hormones in man are poorly defined and evidence that dietary fats may have adverse effects is inconclusive. We investigated whether high-fat meals, which differed in saturated fatty acid (SFA) content acutely modified these hormones. Design: Randomised, double-blind, crossover trial. A high-fat (HF) test meal (5974 g fat; 71% of energy as fat) was given for breakfast on two occasions. Meals comprised either high (B70:30) or low (B55:45) saturated:unsaturated fatty acid (SFA:USFA) ratio. Fasting and postprandial measurements of serum total ghrelin (RIA), leptin (enzyme-linked immunosorbent assay (ELISA)) and insulin (RIA) were made over 6 h. Postprandial measurements were also made at 10 and 24 h following a fat-exclusion lunch, snack and dinner. Subjects: A total of 18 lean, healthy men. Results: There was no significant effect of the fatty meal (time, P40.05), nor a differential effect of SFA:USFA ratio (treatment * time, P40.05) on ghrelin over 6 h. Leptin decreased in response to both HF treatments (time, Po0.001) but increased SFA content did not further inhibit hormone secretion (treatment * time, P40.05). There was no significant correlation between ghrelin or leptin and circulating insulin (P40.05).
Introduction
The hormones ghrelin and leptin both appear to play a role in the regulation of food intake and adiposity. Ghrelin stimulates hunger and promotes food ingestion, whereas leptin may increase satiety and reduce food consumption, at least in animal models, yet the mechanisms which regulate these hormones in man remain poorly defined.
Ghrelin, produced primarily by the stomach, stimulates food intake by increasing hunger (Cummings et al., 2001; Wren et al., 2001) . Fasting increases endogenous levels (Ariyasu et al., 2001; Cummings et al., 2001) , as does dietinduced weight loss (Cummings et al., 2002) and circulating levels are lower in the obese (Shiiya et al., 2002) . There is little response of ghrelin to changes in gastric distension which suggests energy load and nutrient composition rather than volume of food may be the important signalling mechanisms (Shiiya et al., 2002; Callahan et al., 2004) . However, evidence that nutrient intake acutely decreases ghrelin (Tschop et al., 2001; Shiiya et al., 2002) and reduces hunger has recently been questioned since the postprandial decline induced by high-carbohydrate (CHO) feeding (Tschop et al., 2001; Shiiya et al., 2002; Monteleone et al., 2003; Greenman et al., 2004) may not be replicated when intake is high in protein (Erdmann et al., 2003; Knerr et al., 2003; Greenman et al., 2004) or lipid (Monteleone et al., 2003; Erdmann et al., 2004) . A recent study has also shown a potentially adverse increase in endogenous ghrelin circulation following a fatty meal (Erdmann et al., 2004) .
Leptin is secreted predominantly by adipose tissue (Friedman and Halaas, 1998) , is proportional to body fat content (Havel et al., 1996) and may have an antagonistic role to ghrelin (Knerr et al., 2003) . Weight gain increases (Kolaczynski et al., 1996a; Levine et al., 1999) and weight loss decreases (Havel et al., 1996; Weigle et al., 1997; Levine et al., 1999) plasma leptin, but variability between individuals with comparable adipose mass suggests factors other than adipocyte size and lipid content influence leptin production. Hypotheses that rate of change and not total content of adipocyte lipid were critical (Coleman and Herrmann, 1999) led to trials acutely modulating fat balance but the results were disappointing (Murgatroyd et al., 2003) . Fasting (Boden et al., 1996; Kolaczynski et al., 1996a; Weigle et al., 1997) and exercise (Hilton, 2000) cause an acute drop, and overfeeding a rise (Kolaczynski et al., 1996a) in leptin. Whether high-fat (HF) diets associated with obesity may modulate leptin is less clear, failing to alter fasting leptin during energy balance (Schrauwen et al., 1997) and weight stability (Weigle et al., 1997) , or during overfeeding (Dirlewanger et al., 2000) . The postprandial response to HF feeding set against a diurnal change in circulating leptin is even more variable and circulating levels may increase (Dallongeville et al., 1998; Imbeault et al., 2001) , decrease (Havel et al., 1999; Romon et al., 1999; Evans et al., 2001; Imbeault et al., 2001; Koutsari et al., 2003) , or not change (Weigle et al., 1997; Guerci et al., 2000; Monteleone et al., 2003; Tentolouris et al., 2003) following a fatty meal. Changes in both hormones in response to dietary fat are commonly less pronounced than for CHO (Havel et al., 1999; Romon et al., 1999; Monteleone et al., 2003; Greenman et al., 2004) and it has been suggested that insulin may play a critical role in regulation (Evans et al., 2001; Mohlig et al., 2002; Saad et al., 2002; Flanagan et al., 2003; Koutsari et al., 2003; Fogteloo et al., 2004) .
In this study, we wanted to investigate whether a HF meal induced postprandial changes in these peptides and also, since meals rich in saturated fats are known to reduce postprandial insulin sensitivity (Robertson et al., 2002) , whether the composition of dietary fat further modulated the hormonal response to eating.
Methods
Subjects 18 lean healthy young men were recruited into this trial. All subjects provided written informed consent to participate and ethics approval for this study was obtained from the Auckland Ethics Committees, Auckland, New Zealand.
Protocol
This was a double blind, randomised intervention trial where subjects spent 24 h on two separate occasions within the Human Nutrition Unit metabolic facility at the University of Auckland, New Zealand. Participants were given a HF test meal, containing 71% of energy as fat (71 en%), upon arrival and blood samples were collected over 24 h. The test meals contained butter fat with a high or low saturated:unsaturated fatty acid (SFA:USFA) ratio (Table 1 ). The major alterations in the test lipids were a decrease in palmitic acid (16:0) and an increase in oleic (18:1) and linoleic (18:2) acid in the low SFA:USFA treatment group. Details of industrial preparation of this modified dairy fat can be found in a previous publication in which other aspects of this trial were previously reported (Poppitt et al., 2004) .
Participants were randomised such that half of the subjects were allocated high SFA:USFA treatment and half low SFA:USFA treatment during their first 24 h intervention period. All subjects then crossed over on to the other treatment arm for the second period. Treatments were separated by a minimum 3 day washout period during which the subjects returned home and were requested to maintain their usual dietary and exercise habits. During intervention periods the men were confined to the nutrition facility at the University of Auckland and were provided with all meals and snacks. Subjects were maintained in energy balance over 24 h based upon an estimate of basal metabolic rate (BMR) and minimal physical activity during a sedentary day, calculated as 1.4 Â BMR. They arrived fasted at the nutrition unit at 0730 h, an indwelling venous cannula was inserted and a baseline blood sample collected. At 0800 the HF breakfast was served. Subjects were required to consume the breakfast within 15 min. Blood samples were collected at 1, 3, 6 and 10 h. A fat-exclusion lunch was given following the 6 h blood sample, a fat-exclusion afternoon snack at 8 h and a fatexclusion dinner following the 10 h blood sample. Subjects remained within the facility overnight and the final fasted blood sample was collected at 24 h.
Test meals
The two dairy lipids were cooked into blueberry muffins and given with a milk-and sugar-free decaffeinated hot beverage and/or glass of cold water as the HF breakfast test meal. Lipid content of the breakfast was scaled to body size based upon total daily energy intake of each subject. Each muffin contained 5.3 g butter fat per MJ of daily intake. The average total daily intake for the 18 men was 11.270. , the fat-exclusion snack comprised fruit cake and apple juice (0.7 g fat, 1.8 en% fat, 90.6 en% CHO, 7.2 en% protein), the fat-exclusion dinner comprised vegetarian risotto, raspberry dessert, carbonated beverage (2.4 g fat, 2.8 en% fat, 85.1 en% CHO, 9.9 en% protein). These meals and snacks were designed to be identical on both treatment arms.
Analytical methods
Blood samples were centrifuged and serum stored at À801C until later batch analyses of ghrelin, leptin and insulin. Total ghrelin concentrations were measured by radioimmunoassay (RIA) using a Linco Research commercial kit (Saint Charles, MI, USA), using 125 I-labelled ghrelin as the tracer. Primary antibody was rabbit antighrelin, secondary antibody was goat anti-rabbit IgG and precipitation was achieved using polyethylene glycol in a phosphate and Triton-X100 buffer. In all, 100 ml of sample and standards were incubated with primary antibody at 41C overnight. After 24 h 100 ml of tracer was added and incubated overnight at 41C. After 48 h 1.0 ml of precipitating reagent was added, tubes incubated at room temperature for 20 min then centrifuged at 1700 g for 20 min at 41C. The pellets were counted on a Wallac 1480 Wizard gamma counter (Wallac Finland Oy, Turku, Finland) . Linco Research reagents were prepared and stored according to the manufacturer's instructions. Curve fitting and sample concentration were computed using the MultiCalc software supplied with the counter. Coefficient of variation for this assay across the full standards range was 3.3%. The lowest level of detection was 0.311 ng/ml. Serum leptin was measured by enzyme-linked immunosorbent assay (ELISA) using a Duoset commercial kit (R & D System, Minneapolis, USA). 100 ml of sample was applied to 96-well microtitre plates and incubated with the individual coating antibodies for 2 h at room temperature. After washing with PBS, the detection antibodies were applied for another 2 h at room temperature. The bound immune-complexes were detected at 450 nm. The standard curve was generated for every set of samples assayed using the standards provided in the kit. Serum insulin concentrations were measured by RIA using a Peninsula Laboratories commercial kit (Belmont, USA). Polyclonal antibodies from guniea-pig antiserum raised against bovine insulin were incubated with the human insulin standard Actrapid (Novo Nordisk A/S, Bagsvaerd, Denmark) and unknowns. ). Repeated measure ANOVA tested within-diet and between-diet interactions over time periods of 0-1, 0-6 and 0-24 h for each individual parameter. Treatment group, ID, time of sample, run order and block effects were included in the analysis. In all measures, when there was no differential effect of fat quality the two treatments were combined and the quantitative effects of the dietary lipid analysed over time. Baseline comparisons were carried out using paired Student's t-tests. Correlations between leptin, ghrelin and insulin were analysed using Pearson's correlation. Statistical significance was based on 95% limits (Po0.05).
Results
18 men were recruited for this trial. There were no exclusions or drop-outs on either treatment regime. All subjects completed both arms of the intervention. The subjects were young, lean, healthy men. Figure 1 . Over the initial 1 h there was a decrease in circulating ghrelin of up to 12% of baseline on the high SFA:USFA (d ¼ À0.105 ng/ml) and low SFA:USFA (d ¼ À0.106 ng/ml) treatments, but neither decrease reached significance in this trial of 18 men possibly due to high between-subject variability (P40.05). When analysed independent of dietary treatment over the 6 h postprandial period there was no significant effect of the fatty meal per se (time, P40.05), nor were there significant differential effects of the high SFA:USFA or low SFA:USFA treatments (treatment * time, P40.05, Table 2 ) on total ghrelin, although low SFA:USFA treatment kept ghrelin close to 10% below baseline over 6 h, while high SFA:USFA returned to baseline.
Subjects were given an identical high-CHO lunch (L) and afternoon snack (S) on both treatments at 6.5 and 8 h postbreakfast, and ghrelin fell to 12-15% below baseline in both diet groups at 10 h as expected following a high-CHO meal. The overnight fast returned circulating ghrelin to baseline levels on both treatment arms.
Changes in leptin relative to fasting baseline are shown in Figure 2 . The pattern of change in circulating leptin was similar on both high SFA:USFA and low SFA:USFA treatments. When analysed independent of dietary treatment there was a significant decrease between baseline and 6 h (time, Po0.001) over which time leptin decreased by 8% on the high SFA:USFA and 10% on the low SFA:USFA treatment. Circulating leptin was consistently higher on the low SFA:USFA arm at all points between baseline and 6 h (treatment Po0.05, see Table 2 ) but there was no differential change over time in response to treatment group hence the interaction term was not significant at 6 h (treatment * time, P40.05). Following the high-CHO lunch (L) and snack (S) at 6.5 and 8 h, Mean7s.e.m. for 18 lean men. L, lunch; S, snack; D, dinner.
Effect of high-fat meals on ghrelin and leptin SD Poppitt et al respectively, circulating leptin returned to baseline levels by the 10 h blood sample on both treatments. There was a significant change in insulin over 6 h in response to the HF breakfast (time, Po0.001) with a rapid peak at 1 h on both treatments (time, Po0.001), but no differential effects of high SFA:USFA and low SFA:USFA treatment over 6 h (treatment * time, P40.05, Table 2 ). There was no evidence of a significant negative correlation between change in insulin and change in either leptin or ghrelin when calculated both at individual time points 1, 3 and 6 h, and as the area under the curve over 6 h using the premeal blood sample as baseline (P40.05).
Discussion
While there is evidence that ghrelin and to a lesser extent leptin respond to acute changes in energy intake (Kolaczynski et al., 1996a; Weigle et al., 1997; Shiiya et al., 2002; Monteleone et al., 2003; Greenman et al., 2004) , the effect of nutrient composition on their postprandial response is less well understood. Our study of lean men showed a decrease in leptin but not ghrelin over 6 h following a HF meal, and an increase in saturation of the fatty meal did not further alter response of either hormone. Since meals rich in SFA reduce postprandial insulin sensitivity (Robertson et al., 2002) , and insulin may be an important modulator of leptin (Havel et al., 1999; Evans et al., 2001; Koutsari et al., 2003; Romon et al., 2003; Fogteloo et al., 2004) and ghrelin (Mohlig et al., 2002; Saad et al., 2002; Flanagan et al., 2003) , we wanted to determine whether increasing dietary SFA may differentially alter these hormones. Interpretation of the postprandial response of leptin is complicated by diurnal changes in hormone release, driven in part by meal time and/or composition (Schoeller et al., 1997; Fogteloo et al., 2004) , with a decline postbreakfast followed by a midnight peak (Sinha et al., 1996; Coleman and Herrmann, 1999; Havel et al., 1999) . While a high-CHO breakfast may reverse the morning decline (Romon et al., 1999; Evans et al., 2001; Herrmann et al., 2001; Romon et al., 2003) irrespective of meal time (Schoeller et al., 1997) , we had no evidence from our trial of a similar effect following fatty meals.
Although there is growing consensus that insulin is an important regulator of leptin, our review of the literature has shown the data to not yet be conclusive. There is little or no correlation between the two hormones in several postprandial studies (Dagogo-Jack et al., 1996; Sinha et al., 1996; Pratley et al., 1997; Guerci et al., 2000; Herrmann et al., 2001; Poretsky et al., 2001 ) and this has lead to a revived interest in the influence of other dietary nutrients, including lipids, which have a blunted effect on insulin compared to CHO. Other trials which have shown a decrease in leptin after a fatty meal include lean (Romon et al., 1999) and obese subjects (Imbeault et al., 2001) , and where HF test meals have followed high-and low-CHO acclimation (Koutsari et al., 2003) . In a study of lean women given three HF (60 en%) or three high-CHO meals over 24 h, leptin continued to rise from an 0800 h nadir on both treatments but the postprandial response was less pronounced following the HF meals (Havel et al., 1999) . The authors suggested this was due to decreased insulin-mediated glucose metabolism in adipose tissue, and that decreased postprandial exposure of leptin resulting from a fat bolus could be adipogenic (Havel et al., 1999) , citing the hyperphagia and gross obesity resultant in humans from genetic impairment of leptin production (Montague et al., 1997) . Whether a decrease in circulating leptin over 24 h may represent an adverse risk for obesity remains controversial and recombinant leptin weight loss therapy in hyperleptinaemic obese subjects has been met with limited success (Hukshorn et al., 2002; Fogteloo et al., 2003; Lejeune et al., 2003; Wong et al., 2004) . It has been suggested that the role of leptin is not prevention of obesity, rather a response to low-energy availability (Havel, 2004) such that during starvation leptin falls triggering an increase in hunger . Administration of recombinant leptin has resulted in decreased appetite , in line with animal models (Pelleymounter et al., 1995) and also with leptin deficiency and nonfunctional leptin receptor defects which occur rarely in man (Montague et al., 1997) . Not all HF trials however show a decrease in serum leptin. Hormone levels were unchanged in lean and obese subjects given HF meals both morning and evening (Guerci et al., 2000) , in lean (Monteleone et al., 2003) and obese subjects (Weigle et al., 1997) who responded to neither HF or high-CHO, and those who responded to high-CHO but not to HF (Tentolouris et al., 2003) . Numerous studies investigating long-term effects of HF feeding have failed to show a response of fasting leptin to diet (Havel et al., 1996; Schrauwen et al., 1997; Weigle et al., 1997) but the collection of only a morning fasted sample for hormone analysis may make the interpretation of these studies difficult.
The mechanism by which leptin is controlled remains poorly defined. Studies where obese subjects failed to respond to HF or high-CHO led to conclusions that total adipose mass rather than diet may be driving circulating leptin (Weigle et al., 1997) . Gradually the consensus has moved towards insulin playing a pivotal role but the relationship with leptin in the postprandial state is not clear-cut. Cross-sectional studies show an association between fasting leptin and insulin (Rosenbaum et al., 1997) , as do long-term (Kolaczynski et al., 1996b; Boden et al., 1997) but not short-term (Dagogo-Jack et al., 1996) insulin infusion and some postprandial studies (Romon et al., 1999; Koutsari et al., 2003) . Our data were in line with a number of studies which fail to show significant correlation between leptin and insulin after consumption of HF, mixed and even high-CHO meals (Sinha et al., 1996; Pratley et al., 1997; Guerci et al., 2000; Herrmann et al., 2001; Poretsky et al., 2001) . If insulin is a driving force in the control of leptin release (Havel et al., 1999; Romon et al., 1999 Romon et al., , 2003 Evans et al., 2001; Koutsari et al., 2003; Fogteloo et al., 2004) , it is possible that this mechanism is important only when a major portion of the diet comprises CHO.
Total circulating ghrelin is believed to be an important initiator of ingestion in humans. It tends to rise during fasting (Ariyasu et al., 2001; Cummings et al., 2001) , increasing hunger, and fall following a meal (Caixas et al., 2002; Monteleone et al., 2003; Erdmann et al., 2004; Greenman et al., 2004) , decreasing hunger. The consensus that ghrelin decreases postprandially is based mainly on high-CHO trials, however, and trials of obese subjects (English et al., 2002) and also of HF feeding (Mohlig et al., 2002; Erdmann et al., 2004) are less conclusive. Table 3 shows details of four acute HF interventions highlighting the variable outcome of these trials. Ghrelin was unchanged (Mohlig et al., 2002) , decreased (Monteleone et al., 2003; Greenman et al., 2004) and increased (Erdmann et al., 2004) over 1-3 h following a lipid challenge, possible a consequence of the other macronutrient components of the load. Certainly evidence is growing that fatty meals induce a muted response compared with high-CHO meals (Monteleone et al., 2003; Greenman et al., 2004) , and the relative lack of response of ghrelin to both HF regimes in our trial lends support to this idea. Conversely, we should note that although not reaching significance the dietary lipid load did induce a 12% decrease in circulating ghrelin. It is possible that factors such as between-subject variability in glucose control or even previous dietary intake may have reduced the power of this trial to detect this change as statistically significant. Acute changes to the fat loads may also not have been detected using our protocol of blood collection at 1 and 3 h, although data from lean subjects given an 85 en% fat meal (Erdmann et al., 2004) has shown plasma ghrelin to peak at 45-60 min after eating.
Although high-CHO foods appear to elicit the greatest suppression of ghrelin secretion, the role of glucose and/or insulin as initiators of hormone change is not well defined. A number of studies have shown ghrelin to decrease in response to oral (Caixas et al., 2002; Nakagawa et al., 2002; Shiiya et al., 2002) or i.v. glucose (Nakagawa et al., 2002; Shiiya et al., 2002; Briatore et al., 2003) , but others do not (Schaller et al., 2003) . An inhibitory role of insulin on ghrelin has also been shown in some (Mohlig et al., 2002; Saad et al., 2002; Flanagan et al., 2003) but not all (Caixas et al., 2002; Schaller et al., 2003) studies. Physiological hyperinsulinaemia has been shown to decrease ghrelin (Saad et al., 2002) , while increasing insulin and glucose through infusion has not (Caixas et al., 2002) until reaching supraphysiological insulin levels (Schaller et al., 2003) . Two trials in type 1 diabetics lacking endogenous insulin have also been contradictory. When exogenous insulin was withheld and the patients given a mixed high-CHO meal, plasma ghrelin was unaffected (Murdolo et al., 2003) , yet meals with high-and low-glycaemic indices decreased total ghrelin suggesting that insulin was not an essential signal controlling hormone release (Spranger et al., 2003) . Diet-induced changes in insulin also appear unable to explain the differential effects of HF meals on circulating ghrelin (see Table 3 ). Lipid plus CHO caused a high insulin peak but a decrease (Monteleone et al., 2003) or no significant change (our data) in ghrelin. Lipid alone had no effect on insulin but no change (Mohlig et al., 2002) or a decrease (Greenman et al., 2004) in ghrelin. Lipid plus protein had no effect on insulin but an increase in ghrelin (Erdmann et al., 2004) .
In conclusion, this study of lean men has shown that in contrast to high-CHO meals consumption of a fatty meal acutely decreased circulating leptin with no evidence of reversal of the morning nadir, which in turn raises the question of possible adipogenic effects of this decreased postprandial exposure as previously suggested by Havel et al. (1999) . Increasing the saturated fat content of the diet did not further modify circulating leptin. HF meals did not significantly decrease ghrelin below fasting baseline levels, nor was there evidence of a differential effect of fatty acid composition on total ghrelin and no correlation between either of these hormones and circulating insulin. While insulin may be an important regulator of serum leptin and/ or ghrelin when a high-CHO diet is eaten, it may play a lesser role following consumption of fatty meals.
